Skip to content

DENTSPLY SIRONA XRAY Other long-term liabilities

Other long-term liabilities at other companies

IAR
Integra LifeSciencesIART
Amentum Holdings logo
Amentum HoldingsAMTM
Alphatec Holdings logo
Alphatec HoldingsATEC

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$190.0M-52.3%
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%
Free cash flow-$12.0M0.0%

Valuation

See full
Market cap$2.11B-22.1%

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Return on equity-37.7%+4.0pp
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's other long-term liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's other long-term liabilities?
DENTSPLY SIRONA (XRAY) reported other long-term liabilities of -$2M in Q1 2026.
How has DENTSPLY SIRONA's other long-term liabilities changed year-over-year?
DENTSPLY SIRONA's other long-term liabilities increased by 86.7% year-over-year, from -$15M to -$2M.